The high incidence of allergic diseases is one of the major factors driving the growth of this market. The rising environmental pollution levels and the growing need for relatively faster, accurate, and high-throughput technologies for allergy diagnostics are the major factors supporting the growth of this market.

According to the new market research report "Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022", published by MarketsandMarkets™. the Allergy Diagnostics Market is expected to reach USD 5.74 Billion, at a CAGR of 10.5%

The objectives of this study are as follows:

To define, describe, and forecast the global market on the basis of product & service, type of allergen, test, end user, and region

To provide detailed information regarding the major factors influencing market growth (drivers, restraints, and opportunities)

To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701

Allergy Diagnostics Market, by End User:

• Diagnostics Laboratories
• Hospital-based Laboratories
• Academic and Research Institutes

Inhaled allergens are estimated to command the largest market share in 2017

On the basis of allergens, the Allergy Diagnostics Market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2017, the inhaled allergens segment is expected to account for the largest share of the market. Increasing environmental pollution is one of the major factors driving the growth of this segment.

North America estimated to account for the major market share in 2017

Based on region, the Allergy Diagnostics Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2017, North America is expected to command the largest share of the market. The large share of this segment can primarily be attributed to the increasing healthcare expenditure, coverage of allergy diagnostics tests in medical insurance, and the strong presence of players in this region.

Read More In Detailed: https://www.marketsandmarkets.com/Market-Reports/allergy-diagnostics-market-232871701.html

Key players in the Allergy Diagnostics Market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland)